[Minerals]Conflict/Responsible Minerals Update: AMRT (Formerly PRT) 1.2 & EMRT 1.4

11 Dec 2024

Through the previous post, we introduced the core 5-step framework from the OECD Due Diligence Guidance. This time, we will delve into the meaning and details of the new releases of AMRT 1.2 & EMRT 2.0i), announced by RMIii) on September 12, 2024.

  1. RMI Announcement on Upcoming AMRT (formerly PRT) 1.2 and EMRT 2.0 Releases
  2. Responsible Minerals Initiative


AMRT (Additional Minerals Reporting Template)

  • A format where the reporting scope is not specified by designated minerals but is determined by the user.
  • Renamed from PRT (Pilot Reporting Template) 1.1 to AMRT starting with version 1.2.
  • No significant changes in the content; only the naming of the template has been updated.
  • Version 1.2 was released on October 4, 2024.


EMRT (Extended Minerals Reporting Template)

  • Latest version 1.3 expands the reporting scope to include Cobalt and Mica.
  • With the transition to version 2.0, four additional minerals will be added (key minerals used in EV production):
    • Copper, Graphite (natural), Lithium, Nickel
  • Version 2.0 is scheduled for release in April 2025.


RMI Template Downloads

  • Search for the "REPORTING TEMPLATES" menu on the RMI website.



MDSKorea helps businesses comply with global product environmental regulations through Global Product Regulatory Compliance Consulting, Regulatory Chemicals DB Subscription, and Chemical Compliance Analysis Service.

  • Global Product Regulatory Compliance Consulting: Tailored solutions to navigate complex chemical regulations and minimize compliance risks.
  • Regulatory Chemicals DB Subscription: Access up-to-date regulatory chemical lists and amendments for effective compliance.
  • Chemical Compliance Analysis Service: Identify regulated substances and ensure compliance with detailed analysis and guidance.

Contact Us to learn more.


MDSKorea Inc.

  Head Office

314, Gwanggyojungang-ro, Suji-gu, Yongin-si, Gyeonggi-do, Korea

  Seoul Office

173, Digital-ro, Geumcheon-gu, Seoul, Korea 

  Incheon Office

22, Inha-ro 489beon-gil, Namdong-gu, Incheon, Korea 

  Yongin Office

38, Gwanggyojungang-ro, Suji-gu, Yongin-si, Gyeonggi-do, Korea

ⓒ 2023 MDSKorea Inc. All Rights Reserved

MDSKorea Inc.

  Head Office

314, Gwanggyojungang-ro, Suji-gu, Yongin-si, Gyeonggi-do, Korea

  Seoul Office

173, Digital-ro, Geumcheon-gu, Seoul, Korea 

  Incheon Office

22, Inha-ro 489beon-gil, Namdong-gu, Incheon, Korea 

  Yongin Office

38, Gwanggyojungang-ro, Suji-gu, Yongin-si, Gyeonggi-do, Korea

ⓒ 2023 MDSKorea Inc. All Rights Reserved

Request a Consultation

Have questions about our services? 

Submit your inquiry, and our team will get back to you promptly.


MDSKorea Inc.

  Head Office

314, Gwanggyojungang-ro, Suji-gu, Yongin-si, Gyeonggi-do, Korea

  Seoul Office

173, Digital-ro, Geumcheon-gu, Seoul, Korea 

  Incheon Office

22, Inha-ro 489beon-gil, Namdong-gu, Incheon, Korea 

  Yongin Office

38, Gwanggyojungang-ro, Suji-gu, Yongin-si, Gyeonggi-do, Korea

ⓒ 2023 MDSKorea Inc. All Rights Reserved

MDSKorea Inc.

Head Office: 314, Gwanggyojungang-ro, Suji-gu, Yongin-si, Gyeonggi-do, Korea

Seoul Office : 173, Digital-ro, Geumcheon-gu, Seoul, Korea 

Incheon Office : 22, Inha-ro 489beon-gil, Namdong-gu, Incheon, Korea 

Yongin Office: 338, Gwanggyojungang-ro, Suji-gu, Yongin-si, Gyeonggi-do, Korea 

Copyright ⓒ 2023 MDSKorea Inc. All Rights Reserved